This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Simple schizophrenia단순형조현병 (단순형정신분열증)

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: F20.6 (Simple schizophrenia) | Special Copayment Reduction: V161 (severe intractable disease, copayment reduction for 5 years after registration)
B. Synonymssimple schizophrenia
C. Adult onsetPossible first onset in adulthood — simple schizophrenia progresses insidiously from adolescence to early adulthood (ages 15–30), and in the early stage it is perceived as a change in the individual's functioning, so diagnosis is often delayed. It is common for the first clinical evaluation to take place in early adulthood (the 20s).
1. HistoryBleuler's description of 'simple schizophrenia (Schizophrenia simplex)' (1911) → included in ICD-10 F20.6 → excluded from DSM-III and IV, and also excluded from DSM-5 → controversy over diagnostic validity continues.
2. CausesCommon genetic vulnerability to schizophrenia and neurodevelopmental abnormality; the cause of the unusual phenotype showing only negative symptoms without positive symptoms from the onset has not been established.
3. GeneticsSchizophrenia spectrum genetic risk; genetic continuity with schizotypal personality disorder (schizotypal PD); possible genetic variants related to negative symptoms.
4. General epidemiologyA rare diagnosis, about 1–5% of all schizophrenia; diagnosis may be underreported because of strict diagnostic criteria; slightly more common in men with earlier onset.
5. PathophysiologySelective and progressive decline of prefrontal function; hypodopaminergic phenotype; located at the severe end of the schizotypy continuum.
6. SymptomsInsidious progression with negative symptoms alone (avolition, anhedonia, social withdrawal, flat affect) without delusions or hallucinations; course of premorbid functional decline → social isolation → self-neglect.
7. SignsReduced goal-directed behavior, reduced facial expression, avoidance of social interaction; high SANS, no positive symptoms; odd ideas or perceptual abnormalities may be reported mildly.
8. ScreeningScreening for schizotypal personality traits (SPQ, STA); schizophrenia spectrum screening; early detection of functional change in adolescents; negative symptoms assessed with SANS and BNSS.
9. DiagnosisICD-10 F20.6: persistent negative symptoms and functional decline for 1 year or longer without clear delusions or hallucinations; differentiation from schizotypal personality disorder, depression, and autism spectrum disorder is key.
10. TreatmentLow-dose antipsychotic drugs; cognitive remediation and social skills training are relatively more important than medication; strengthen community support; add an antidepressant when depression accompanies.
11. PrognosisInsidiously progressive functional decline; complete remission is rare but functional stabilization is possible; some progress to typical schizophrenia episodes (positive symptoms).
12. PreventionEarly detection of persons at high risk in the schizophrenia spectrum; early intervention for functional decline; prevention of social isolation; maintenance of function through psychosocial support.
13. ReferencesMueser KT, McGurk SR. Schizophrenia. Lancet. 2004 … and 9 other papers

1. History

The history of simple schizophrenia begins with the first systematic description by Eugen Bleuler in 1911 in his work 'Dementia Praecox or the Group of Schizophrenias'. Bleuler named the form that progresses insidiously with only the fundamental symptoms of schizophrenia (loosening of associations, affective disturbance, autism, ambivalence), without clear positive symptoms (delusions, auditory hallucinations), 'simple schizophrenia (Schizophrenia simplex)'. He emphasized that this form often goes unrecognized despite its diagnostic difficulty and clinical importance.

In German psychiatry at the end of the 19th century, Kraepelin also described cases among dementia praecox in which the personality deteriorated insidiously without clear acute episodes, but he did not specify the simple type as an independent subtype. Bleuler's concept of the simple type reflects the clinical reality that schizophrenia need not pass through an acute psychotic episode, but can present with negative symptoms alone from the start.

In the ICD system of the mid-20th century, the simple type was repeatedly included and excluded. It was included in ICD-9 (1978) but excluded from DSM-III (1980). The reason was concern that diagnosing schizophrenia with negative symptoms alone, without delusions or hallucinations, undermines diagnostic reliability and makes differentiation from simple personality disorder or depression difficult. It remained excluded in DSM-IV (1994) as well.

ICD-10 (1992) formally included simple schizophrenia as F20.6. The ICD-10 criteria for the simple type require gradual functional decline and development of negative symptoms for at least 1 year without positive symptoms, and sought to set a strict boundary with schizotypal personality disorder. The simple type was also not included in DSM-5 (2013). However, DSM-5 allows cases corresponding to the simple type to be described under the category 'other specified schizophrenia spectrum and other psychotic disorder'.

The debate over the diagnostic validity of simple schizophrenia continues today. Proponents argue that this diagnosis is a distinct clinical form at one end of the schizophrenia spectrum that requires appropriate treatment and support. Opponents argue that diagnostic reliability is low and it is hard to distinguish from schizotypal personality disorder, depressive disorders, and others. ICD-11 (2022) includes the simple type as 'simple schizophrenia' but requires strict criteria, and in Korean clinical practice F20.6 continues to be used.


2. Causes

The cause of simple schizophrenia is understood within the vulnerability-stress model framework of schizophrenia in general, but the cause of the unusual phenotype showing only negative symptoms without positive symptoms from the onset has not been clearly established.

Genetic vulnerability and neurodevelopmental abnormality: The common genetic predisposition to schizophrenia also applies to the simple type. There are reports that the proportion of schizophrenia, schizotypal personality disorder (schizotypal PD), and schizoid personality disorder (schizoid PD) is high among family members of patients with the simple type, suggesting that genetic vulnerability in the schizophrenia spectrum is distributed continuously. There is a hypothesis that neurodevelopmental abnormality selectively impairs prefrontal function, forming a phenotype expressed only as negative symptoms from the start.

Hypodopaminergic phenotype: Simple schizophrenia is explained as a 'hypodopaminergic' phenotype in which prefrontal cortical dopamine reduction (basis of negative symptoms) predominates over mesolimbic dopamine hyperactivity (basis of positive symptoms). This is a neurochemical hypothesis explaining why the simple type has no positive symptoms and shows only negative symptoms.

Environmental factors: Social isolation, gradual worsening of social withdrawal in adolescence, and accumulated academic and occupational failures form the environmental context for the onset and progression of the simple type. However, whether these are causes or consequences is unclear. There are reports that cannabis use can reinforce a state resembling negative symptoms.


3. Genetics

The genetics of simple schizophrenia is understood from the perspective of genetic continuity across the schizophrenia spectrum. Genetic studies specific to the simple type are extremely limited.

Genetic continuity of the schizophrenia spectrum: Simple schizophrenia appears to form a continuum genetically with schizophrenia, schizotypal personality disorder, and schizoid personality disorder. These conditions partly share common genetic vulnerability while forming a spectrum of clinical expression. The simple type lies at the negative-symptom end of this spectrum.

Genes related to negative symptoms: Studies suggesting that variants of genes related to prefrontal function, such as DTNBP1, NRG1, and COMT, are associated with vulnerability to negative symptoms may also apply to the simple type. There is evidence that the COMT Val158Met polymorphism (high COMT activity, reduced prefrontal dopamine) is associated with the schizophrenia phenotype with prominent negative symptoms.

Genetic overlap with schizotypal personality disorder: Schizotypal personality disorder (F21) is the main differential diagnosis of simple schizophrenia and a neighboring condition on the genetic continuum. In family studies, the proportion of schizotypal personality disorder is high among family members of patients with schizophrenia, and conversely the proportion of schizophrenia is high among family members of patients with schizotypal personality disorder. This continuity is also the reason differentiating simple schizophrenia from schizotypal personality disorder is clinically difficult.


4. General epidemiology

Simple schizophrenia is one of the least frequently diagnosed subtypes of schizophrenia. Because of strict diagnostic criteria and low diagnostic awareness, the actual prevalence may be underestimated.

Prevalence: By ICD-10 criteria, simple schizophrenia is reported at about 1–5% of all schizophrenia, and in practice this code is used very infrequently. Some studies estimate that many cases meeting the simple type criteria have been diagnosed as schizotypal personality disorder or depressive disorder, suggesting that the diagnosis of the simple type is being underapplied.

Age of onset and sex: Age of onset is the second earliest among schizophrenia subtypes after the hebephrenic type, beginning insidiously mainly at ages 15–25. It is slightly more common in men, who show earlier onset. Because of the insidiously progressive nature, the delay until the first clinical visit is long, and the course has often already lasted several years at diagnosis.

Diagnostic delay: The most serious epidemiological problem of simple schizophrenia is diagnostic delay. Without clear psychotic symptoms, the patient and family find it hard to recognize anything wrong, and the doctor seen first often judges it to be a personality change or depression. It is not uncommon for diagnosis to take an average of 5–10 years.

Epidemiology in Korea: Use of the F20.6 code is very rare in Korea, and many cases corresponding to the simple type may have been diagnosed as F21 (schizotypal personality disorder), F20.5 (residual schizophrenia), or F32 (depressive episode). Raising awareness of the clinical usefulness of the simple type diagnosis among psychiatric specialists in Korea is a challenge.


5. Pathophysiology

The pathophysiology of simple schizophrenia is characterized by progressive decline of prefrontal function and a hypodopaminergic phenotype.

Progressive decline of prefrontal function: The core of the simple type is selective and progressive decline of prefrontal cortex (PFC) function. In fMRI studies, patients with simple schizophrenia show persistently reduced PFC activation during cognitive tasks, which is the neuroscientific basis of avolition, impaired executive function, and alogia. It is a characteristic of the simple type that this decline does not appear suddenly, as in typical schizophrenia, but progresses gradually over years.

Hypodopaminergic hypothesis: The simple type is understood as a 'dopamine-deficient phenotype' in which mesolimbic dopamine hyperactivity (basis of positive symptoms) is not prominent and mesocortical dopamine reduction (basis of negative symptoms) predominates. This explains why the effect of antipsychotic drugs (D2 blockers) is limited in this phenotype.

Schizotypy continuum and gradual progression: The simple type is located at the severe end of the continuum of normal 'schizotypal traits (schizotypy)'. A continuous process that begins with mild social withdrawal and cognitive eccentricity and gradually deepens into negative symptoms constitutes the pathophysiology of simple schizophrenia. This is understood as a model in which the expression of vulnerability emerges gradually through internal neurodevelopmental processes even without environmental stress.


6. Symptoms

The most important clinical feature of simple schizophrenia is that it progresses insidiously with negative symptoms alone, without clear delusions or hallucinations. This is the key feature that distinguishes it from all other schizophrenia subtypes.

Gradual development of negative symptoms: Over months to years, avolition, anhedonia, flat affect, social withdrawal, and alogia deepen gradually. It first begins with observations by those around the patient such as 'personality has changed', 'has lost motivation', and 'avoids people'. Functional decline in school, work, and interpersonal relationships progresses slowly, and interest in previously enjoyed activities decreases.

Absence or mildness of positive symptoms: Typical schizophrenic delusions (persecutory delusions, delusions of reference) or auditory hallucinations are absent, or if present, very mild and transient. Mild perceptual abnormalities (vague feelings, odd perceptions) or vague ideas of reference may be reported, but these do not dominate the clinical picture.

Gradual social isolation: The social network gradually shrinks, and interpersonal relationships outside the family disappear. It progresses to a form in which the patient does not leave the room or maintains only minimal social interaction. This social isolation forms a vicious cycle that further reinforces negative symptoms.

Gradual decline in self-care: Personal hygiene, eating, and clothing care slowly deteriorate. This results from the combination of reduced motivation due to negative symptoms and reduced self-awareness. Because this process progresses over years, families often initially misinterpret it as 'laziness' or 'rebelliousness'.


7. Signs

The clinical signs of simple schizophrenia are predominantly negative symptoms, and the feature is that no positive symptoms are observed on mental status examination.

Mental status examination findings: Facial expression is reduced or blank, and eye contact is decreased. Spontaneous speech is reduced and short answers predominate. Attention is reduced, and it appears difficult to maintain concentration during the interview. Clear delusions or hallucinations are not reported, or if present, are very mild and transient. Thought content is poor and there are few interests.

Objective confirmation of functional decline: The Global Assessment of Functioning (GAF) score is low, and family or others around the patient confirm that current functioning is markedly reduced compared with before the illness. Functional decline is observed in work, school, interpersonal relationships, and self-care.

SANS and negative symptom scales: High scores are found on the SANS (Scale for Assessment of Negative Symptoms) or BNSS (Brief Negative Symptom Scale). Scores are elevated in all five negative symptom domains (flat affect, alogia, avolition, anhedonia, social withdrawal).

Schizotypal features: Mild schizotypal features (odd ideas, unusual perceptual experiences, magical thinking) may be observed. This is a factor that makes differentiation from schizotypal personality disorder difficult. If there are schizotypal features but functional decline is more severe and progressive, the case is closer to simple schizophrenia.


8. Screening

Early detection of simple schizophrenia centers on early screening for negative symptoms and capturing functional change.

Schizophrenia spectrum screening instruments: The Schizotypal Personality Questionnaire (SPQ), Structured Interview for Schizotypy (SIS), and others are used to assess schizotypal traits and capture the spectrum characteristics of simple schizophrenia. The Schizotypy Scale (STA) is used for a similar purpose.

Negative symptom screening: Negative symptoms are quantified with SANS, BNSS, and NSA-16. In particular, longitudinally tracking the course in which reduced motivation and social withdrawal gradually deepen is the key to diagnosing the simple type.

Assessment of functional change: The current functional level is compared with the premorbid functional baseline using the Global Assessment of Functioning (GAF) or the Personal and Social Performance Scale (PSP). Confirmation of functional decline lasting at least 1 year is a diagnostic requirement.

Early detection in adolescent settings: A sharp drop in school grades, social withdrawal, and loss of peer relationships are early signs of the simple type. Early detection systems in school counselors and adolescent mental health services are important. Attention should be paid to elevated scores on the withdrawn and thought problems subscales of the K-YSR and CBCL.


9. Diagnosis

Diagnosis of simple schizophrenia is a difficult diagnosis requiring application of strict criteria and sufficient longitudinal observation.

ICD-10 F20.6 diagnostic criteria: ① At least one of the following must develop gradually over at least 1 year: (a) negative symptoms (avolition, flat affect, social withdrawal), (b) odd behavior (self-neglect, social isolation), (c) poverty of thought, (d) decline in activity and performance. ② There must have been no clear schizophrenic symptoms (delusions, auditory hallucinations, thought disorganization) during this period. ③ Functional decline must be evident compared with before the illness. ④ Other causes such as brain damage, substance use, and depressive disorder must be excluded.

Main differential diagnoses: ① Schizotypal personality disorder (F21): most similar to the simple type, but in schizotypal disorder functional decline is less severe and odd cognitive and perceptual experiences (magical thinking, odd perceptual experiences) are prominent. If functional decline is more severe and progressive, the likelihood of a simple type diagnosis is high. ② Schizoid personality disorder (F60.1): reduced emotional expression and social isolation are similar, but these are persistent traits since before the illness, without progressive functional decline. ③ Major depressive disorder: avolition, anhedonia, and social withdrawal are shared, but in depression subjective sadness, guilt, and sleep changes are in the foreground. ④ Autism spectrum disorder (ASD): abnormal social communication and restricted interests are shared, but ASD appears from early development and is not progressive.


10. Treatment

Treatment of simple schizophrenia must be designed to suit its character as a state dominated by negative symptoms without positive symptoms. The role of antipsychotic drugs is more limited than in other subtypes.

Antipsychotic drugs: The effect of antipsychotic drugs on negative symptoms is generally limited, but low-dose second-generation antipsychotics are used. There is evidence that amisulpride at low doses (50–300 mg/day) actually stimulates dopamine release by blocking prefrontal D2/D3 receptors and has some effect on negative symptoms. Aripiprazole, as a D2 partial agonist, may also show some effect in a hypodopaminergic state. Clozapine has a relative advantage in treatment-resistant negative symptoms.

Non-pharmacological treatment — relative importance of the psychosocial approach: In the simple type, psychosocial treatment plays a relatively more important role than medication. Cognitive remediation (CRT), social skills training, and behavioral activation are effective for improving negative symptoms. Prevocational training and supported employment aim at recovery of social function. Family psychoeducation helps the family understand negative symptoms and avoid overstimulation or excessive demands.

Treatment of accompanying depression: Depressive symptoms often accompany in patients with the simple type, so regular assessment with the CDSS is performed, and an SSRI is added if depression is confirmed. Treating depression sometimes leads to improvement of avolition and anhedonia.

Community support: Community support through day hospitals, psychiatric rehabilitation facilities, and ACT teams is essential for maintaining function and preventing isolation in patients with the simple type. As the illness worsens when social isolation progresses, a structured environment maintaining regular social contact is essential.


11. Prognosis

The prognosis of simple schizophrenia is characterized by insidiously progressive functional decline; complete remission is rare, but functional stabilization is possible with early intervention and active support.

Long-term course: In long-term follow-up studies, about 50–70% of patients with the simple type gradually lose function and, after several decades, reach a state in which independent living is difficult or impossible. However, in about 20–30% function stabilizes or partly recovers. In some patients, typical schizophrenia episodes (positive symptoms such as delusions and auditory hallucinations) appear during the course, and the diagnosis is changed to another subtype.

Prognostic predictors: Factors associated with good prognosis include early diagnosis (the shorter the diagnostic delay), family support, and sustained participation in psychosocial treatment. Poor prognosis is associated with long diagnostic delay, severe social isolation, lack of family support, and substance use.

Suicide risk: Accompanying depression is also common in simple schizophrenia, and suicide risk assessment is essential. When insight is partly preserved and the patient recognizes his or her own decline in social function and isolation, hopelessness and suicidal impulses may appear.


12. Prevention

Prevention of simple schizophrenia centers on early detection of groups at high risk in the schizophrenia spectrum and preemptive intervention for functional decline.

Early detection of groups at high risk in the schizophrenia spectrum: It is important to capture the prodromal state of simple schizophrenia in adolescents and young adults with schizotypal personality traits, mild social withdrawal, and early functional decline. School counseling, adolescent mental health services, and university mental health centers take on this role.

Prevention of social isolation: When social isolation progresses, a vicious cycle forms in which negative symptoms deepen. Maintaining social activities, supporting peer relationships, and participating in community programs have a preventive effect. Family understanding and active involvement are key to preventing isolation.

Shortening diagnostic delay: To reduce diagnostic delay, the biggest problem in simple schizophrenia, education of primary care physicians and non-psychiatric health professionals is needed. The ability to recognize negative symptoms and insidiously progressive functional decline as a possible sign of the schizophrenia spectrum is required.

Early intervention for functional decline: Psychosocial interventions (social skills training, prevocational training, family education) are started early, when functional decline is first recognized, to minimize the progression of functional decline.


13. References

  1. Mueser KT, McGurk SR. Schizophrenia. Lancet. 2004;363(9426):2063-2072. DOI: 10.1016/S0140-6736(04)16458-1. PMID: 15207959.

  2. Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, "Just the Facts" 5. Treatment and prevention. Past, present, and future. Schizophr Res. 2010;122(1-3):1-23. DOI: 10.1016/j.schres.2010.05.025. PMID: 20571941.

  3. Galderisi S, Mucci A, Buchanan RW, Arango C. Negative symptoms of schizophrenia: new developments and unanswered research questions. Lancet Psychiatry. 2018;5(8):664-677. DOI: 10.1016/S2215-0366(18)30050-4. PMID: 29909215.

  4. Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399(10323):473-486. DOI: 10.1016/S0140-6736(21)01730-X. PMID: 35093236.

  5. Heckers S, Barch DM, Bustillo J, et al. Structure of the psychotic disorders classification in DSM-5. Schizophr Res. 2013;150(1):11-14. DOI: 10.1016/j.schres.2013.04.039. PMID: 23707641.

  6. Fonseca-Pedrero E, Ortuño-Sierra J, Sierro G, et al. The measurement of schizotypy across countries: measurement invariance of the Oxford-Liverpool Inventory of Feelings and Experiences across 18 countries. Schizophr Bull. 2018;44(3):522-532. DOI: 10.1093/schbul/sbx023. PMID: 28338819.

  7. Kahn RS, Sommer IE, Murray RM, et al. Schizophrenia. Nat Rev Dis Primers. 2015;1:15067. DOI: 10.1038/nrdp.2015.67. PMID: 27189524.

  8. Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951-962. DOI: 10.1016/S0140-6736(13)60733-3. PMID: 23810019.

  9. National Institute for Health and Care Excellence (NICE). Psychosis and schizophrenia in adults: prevention and management. NICE guideline CG178. 2014 (updated 2019). Available at: https://www.nice.org.uk/guidance/cg178.

  10. Fusar-Poli P, Howes O, Bechdolf A, Borgwardt S. Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies. J Psychiatry Neurosci. 2012;37(3):170-184. DOI: 10.1503/jpn.110061. PMID: 22243632.